Skip to main content

Table 6 Baseline demographic and clinical characteristics of the patients with COPD included in the RECODE study

From: RECODE: Design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care

 

Total (n = 1086)

Men,%

53.9

Age, y

68.3 (11.2)

Employment,%

28.3

Low education,%

40.3

Pulmonary function 1

 

 Predicted FEV1**%

67.8

 FER***%

57.7

GOLD-stage,% ****

 

 I Mild

24.6

 II Moderate

53.2

 III Severe

19.4

 IV Very severe

2.9

Smoking status,%

 

 Current

36.7

 Former

53.2

 Never

10.1

Co-morbidities

 

 Major cardiovascular disease,%

16.1

 Hypertension,%

36.8

 Diabetes,%

14.7

 Depression,%

9.9

 Charlson co-morbidity index

2.3 (1.3)

CCQ

 

 Symptoms

2.09 (1.21)

 Functional state

1.40 (1.22)

 Mental state

0.51 (0.98)

 Total score

1.50 (0.97)

MRC

 

 score ≤2.%

66.6

 score >2.%

33.4

 MRC score (mean)

2.01 (1.28)

SGRQ

 

 Symptom

50.5 (20.9)

 Activity

47.8 (29.5)

 Impact

23.3 (19.6)

 Total

35.6 (20.5)

EQ-5D

 

 Total score

0.74 (0.26)

 EQ-VAS

67.0 (17.4)

SF-36

 

 Physical

38.3 (10.8)

 Mental

48.6 (10.4)

IPAQ

 

 Total MET minutes

2925 (4683)

 High physical activity,%

11.1

 Moderate physical activity,%

0.6

 Low physical activity,%

88.4

Self-management

 

 Taking initiatives

57.0 (17.9)

 Investment behavior

60.4 (17.6)

 Self-efficacy

65.3 (17.4)

  1. *Values are means and corresponding standard deviations (SD) unless stated otherwise. **FEV1 predicted: Forced expiratory volume in 1 second, post-bronchodilator, predicted according to age and height. ***FER: forced expiratory ratio (FEV1 / FVC x 100%), FVC: forced vital capacity. ****Mild = FEV1 > 80%, Moderate = 50% ≤ FEV1 < 80%, Severe = 30% ≤ FEV1 <50%, Very severe = FEV1 < 30%
  2. 1. Lungfunction was missing in 66 patients (34 control patients; 32 intervention patients).